Stock A059210 META BIOMED CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Meta Biomed Co., Ltd.

Equities

A059210

KR7059210005

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 29/05/2024 am IST 		5-day change 1st Jan Change
4,790 KRW -0.42% Intraday chart for Meta Biomed Co., Ltd. -7.17% +9.86%
15/03 Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till March 16, 2026. CI
11/03 Meta Biomed Co., Ltd. announced that it has received KRW 24 billion in funding from Mirae Asset Securities Co., Ltd., Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., KB-Suseong No. 1 New Technology Business Investment Association CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till March 16, 2026.
CI
Meta Biomed Co., Ltd. announced that it has received KRW 24 billion in funding from Mirae Asset Securities Co., Ltd., Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., KB-Suseong No. 1 New Technology Business Investment Association
CI
Meta Biomed Co., Ltd. announced that it expects to receive KRW 24 billion in funding from Mirae Asset Securities Co., Ltd., Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., KB-Suseong No. 1 New Technology Business Investment Association and another investor
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till October 28, 2025.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till August 5, 2025.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till April 9, 2025.
CI
Meta Biomed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tranche Update on Meta Biomed Co., Ltd.'s Equity Buyback Plan announced on June 29, 2022.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till September 11, 2024.
CI
Meta Biomed Co., Ltd. announces an Equity Buyback for KRW 500 million worth of its shares.
CI
Meta Biomed Co., Ltd. authorizes a Buyback Plan.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till March 16, 2024.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till October 28, 2023.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till August 5, 2023.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till April 9, 2023.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till September 11, 2022.
CI
Meta Biomed Co., Ltd. announces an Equity Buyback for KRW 500 million worth of its shares.
CI
Meta Biomed Co., Ltd. authorizes a Buyback Plan.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till October 28, 2021.
CI
Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till September 11, 2020.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A059210 Stock
  4. News Meta Biomed Co., Ltd.